SMAD2 and polycystic ovary syndrome: Collectively, our findings illuminate the Inhba/Smad2/E2f4 axis as a central driver of TCs proliferation in PCOS and underscore its potential as a target for developing molecular therapies aimed at addressing the underlying pathophysiology of this complex disorder.